Share
21,829 Posts.
lightbulb Created with Sketch. 893
clock Created with Sketch.
27/08/15
19:52
Share
Originally posted by sheaf
↑
I really, really don't want to sound like q^9, but (1) I agree, I think it will be some time before the new CEO is appointed. Even for much lesser roles in places I worked, it easily took 3-4 months to fill a role. And (2), we all appear to be assuming that the review and subsequent announcement of priorities and direction will be something that will propel the SP upwards, but other than removing some of the uncertainties (which is not a bad thing), it won't have any effect on the technologies or the clinical trials, and so I can't see it being the cure for the current SP woes.
May be I am just worn out by the continual and painful downward spiral. I think the only thing that will provide a sustained support for the SP is an announcement on the commencement of clinical trials and subsequent announcements on their success. There you go, I am sounding just like q^9...
Expand
Sheaf
Well said
You are only being realistic,fair and reasonable
I can't see any news regarding human trials until new CEO has reviewed nrt's portfolio and outlined the direction they will pursue going forward
Glah